CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 277 filers reported holding CRISPR THERAPEUTICS AG in Q2 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $218,946 | -11.0% | 3,900 | +77.3% | 0.01% | -37.5% |
| Q3 2021 | $246,000 | -24.1% | 2,200 | +10.0% | 0.02% | -27.3% |
| Q2 2021 | $324,000 | +117.4% | 2,000 | +63.9% | 0.02% | +100.0% |
| Q1 2021 | $149,000 | +547.8% | 1,220 | +123.9% | 0.01% | +266.7% |
| Q1 2020 | $23,000 | +91.7% | 545 | +179.5% | 0.00% | +50.0% |
| Q4 2019 | $12,000 | +50.0% | 195 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $8,000 | +14.3% | 195 | +25.8% | 0.00% | 0.0% |
| Q2 2019 | $7,000 | +16.7% | 155 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | +50.0% | 155 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -42.9% | 155 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | -30.0% | 155 | -9.4% | 0.00% | -50.0% |
| Q2 2018 | $10,000 | +900.0% | 171 | +968.8% | 0.00% | – |
| Q1 2018 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |